Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The current concepts of the pathogenesis of emphysema hold that progressive, chronic destruction of the alveolar structures occurs because there was in imbalance between the proteases and antiproteases in the lower respiratory tract. In this context, proteases, particularly neutrophil elastase, work unimpeded to destroy the alveolar structures. This concept has evolved from consideration of patients with alpha 1-antitrypsin deficiency, who have decreased levels of serum alpha 1-antitrypsin and who have progressive panacinar emphysema. To directly assess the antiprotease side of this equation, the lower respiratory tract of non-smoking individuals with normal serum antiproteases and individuals with PiZ homozygous alpha 1-antitrypsin deficiency underwent bronchoalveolar lavage to evaluate the antiprotease screen of their lower respiratory tract. These studies demonstrated that: (a) alpha 1-antitrypsin is the major antielastase of the normal human lower respiratory tract; (b) alpha 2-macroglobulin, a large serum antielastase, and the bronchial mucous inhibitor, an antielastase of the central airways, do not contribute to the antielastase protection of the human alveolar structures; (c) individuals with PiZ alpha 1-antitrypsin deficiency have little or no alpha 1-antitrypsin in their lower respiratory tract and have no alternative antiprotease protection against neutrophil elastase; and (d) the lack of antiprotease protection of the lower respiratory tract of PiZ individuals is a chronic process, suggesting their vulnerability to neutrophil elastase is always present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunochemical quantitation of antigens by single radial immunodiffusion
Mancini, G., Carbonara, A. O., & Heremans, J. F. (1965) · Immunochemistry · doi:10.1016/0019-2791(65)90004-2 · Cited by 9,139
Antigen-antibody crossed electrophoresis
Laurell, C.-B. (1965) · Analytical Biochemistry · doi:10.1016/0003-2697(65)90278-2 · Cited by 1,415
Hunninghake, G. W., Gadek, J. E., Kawanami, O., Ferrans, V. J., & Crystal, R. G. (1979) · PubMed Central · Cited by 941
Self-citationCRYSTAL, R. G., FULMER, J. D., ROBERTS, W. C., MOSS, M. L., LINE, B. R., & REYNOLDS, H. Y. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-6-769 · Cited by 685
Self-citationTreatment of Hereditary Angioedema with Danazol: Reversal of Clinical and Biochemical Abnormalities
Gelfand, J. A., Sherins, R. J., Alling, D. W., & Frank, M. M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197612232952602 · Cited by 607
Enzyme-linked immunoassay (ELISA) for connective tissue components
Rennard, S. I., Berg, R., Martin, G. R., Foidart, J. M., & Robey, P. G. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90300-0 · Cited by 605
Self-citationNatural History and Life Expectancy in Severe Alpha1‐Antitrypsin Deficiency, Pi Z
Larsson, C. (1978) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1978.tb08452.x · Cited by 484
Animal Models of Emphysema 1– 3
Snider, G. L., Lucey, E. C., & Stone, P. J. (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.133.1.149 · Cited by 438
Gadek, J. E., Fells, G. A., & Crystal, R. G. (1979) · Science · doi:10.1126/science.316188 · Cited by 401
Self-citationWeeke, B. (1973) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1973.tb03777.x · Cited by 352
Cited by
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.168.7.818 · Cited by 911
Stoller, J. K., & Aboussouan, L. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66781-5 · Cited by 695
Replacement Therapy for Alpha1-Antitrypsin Deficiency Associated with Emphysema
Wewers, M. D., Casolaro, M. A., Sellers, S. E., Swayze, S. C., McPhaul, K. M., Wittes, J. T., & Crystal, R. G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704233161704 · Cited by 641
Self-citationStructure and variation of human α1–antitrypsin
Carrell, R. W., Jeppsson, J.-O., Laurell, C.-B., Brennan, S. O., Owen, M. C., Vaughan, L., & Boswell, D. R. (1982) · Nature · doi:10.1038/298329a0 · Cited by 617
Molecular basis of alpha-1-antitrypsin deficiency
Brantly, M., Nukiwa, T., & Crystal, R. G. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90154-4 · Cited by 521
Self-citationChapman, K. R., Burdon, J. G. W., Piitulainen, E., Sandhaus, R. A., Seersholm, N., Stocks, J. M., Stoel, B. C., Huang, L., Yao, Z., Edelman, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60860-1 · Cited by 514
A Randomized Clinical Trial of α 1 -Antitrypsin Augmentation Therapy
DIRKSEN, A., DIJKMAN, J. H., MADSEN, F., STOEL, B., HUTCHISON, D. C. S., ULRIK, C. S., SKOVGAARD, L. T., KOK-JENSEN, A., RUDOLPHUS, A., SEERSHOLM, N., et al. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9901055 · Cited by 498
Crystal, R. G. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114578 · Cited by 495
Self-citationStoller, J., Snider, G., Brantly, M., Fallat, R., Stockley, R., Turino, G., Konietzko, N., Dirksen, A., Eden, E., Fallat, R., et al. (2005) · Pneumologie · doi:10.1055/s-2004-830176 · Cited by 477
Smoking: Health Effects and Control
Fielding, J. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508223130807 · Cited by 458
Survival and FEV 1 Decline in Individuals with Severe Deficiency of α 1 -Antitrypsin
The Alpha-1-Antitrypsin Deficiency Registry Study Group (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9712017 · Cited by 435
Lung Epithelium–specific Proteins: Characteristics and Potential Applications as Markers
HERMANS, C., & BERNARD, A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.2.9806064 · Cited by 428
(1989) · European Respiratory Journal · doi:10.1183/09031936.93.02060561 · Cited by 391
The Neutrophil in Chronic Obstructive Pulmonary Disease. Too Little, Too Late or Too Much, Too Soon?
Hoenderdos, K., & Condliffe, A. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0492tr · Cited by 389
Greene, C. M., Marciniak, S. J., Teckman, J., Ferrarotti, I., Brantly, M. L., Lomas, D. A., Stoller, J. K., & McElvaney, N. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.51 · Cited by 324
Neutrophils and the Pathogenesis of COPD
Stockley, R. A. (2002) · Chest · doi:10.1378/chest.121.5_suppl.151s · Cited by 323
Rao, N. V., Wehner, N. G., Marshall, B. C., Gray, W. R., Gray, B. H., & Hoidal, J. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92854-1 · Cited by 301
Kohno, N., Awaya, Y., Oyama, T., Yamakido, M., Akiyama, M., Inoue, Y., Yokoyama, A., Hamada, H., Fujioka, S., & Hiwada, K. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.3.637 · Cited by 286
Gadek, J. E., Klein, H. G., Holland, P. V., & Crystal, R. G. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110360 · Cited by 278
Self-citationTaggart, C., Cervantes-Laurean, D., Kim, G., McElvaney, N. G., Wehr, N., Moss, J., & Levine, R. L. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61505-x · Cited by 269
Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms
McGuinness, A., & Sapey, E. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6020021 · Cited by 243
“Neutrophil elastase is inhibited in a 1:1 molar complex by α1AT [67], an anti-proteinase.”
BackgroundHubbard, R. C., Ogushi, F., Fells, G. A., Cantin, A. M., Jallat, S., Courtney, M., & Crystal, R. G. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113204 · Cited by 157
Self-citationRecent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases
Sahu, I., Haque, A. K. M. A., Weidensee, B., Weinmann, P., & Kormann, M. S. D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.019 · Cited by 104
O’Brien, M. E., Murray, G., Gogoi, D., Yusuf, A., McCarthy, C., Wormald, M. R., Casey, M., Gabillard-Lefort, C., McElvaney, N. G., & Reeves, E. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052441 · Cited by 91
Genetic Modification of the Lung Directed Toward Treatment of Human Disease
Sondhi, D., Stiles, K. M., De, B. P., & Crystal, R. G. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.152 · Cited by 36
Self-citation
Metadata
- Authors
- Gadek, J. E., Fells, G. A., Zimmerman, R. L., Rennard, S. I., & Crystal, R. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1981-10-01
- Volume
- 68
- Issue
- 4
- Pages
- 889-898
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2107111755
- Cited by
- 429
- References
- 23
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.